Content » Vol 92, Issue 4

Letter to the Editor

Erythrodermic Psoriasis Improved by Panitumumab, But Not Bevacizumab

Licenses
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.